Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2008/062830
Kind Code:
A1
Abstract:
Disclosed is a novel spiroquinone derivative having high ABCA1 stabilization effect, which is useful as an agent for prevention and/or treatment of various diseases accompanied by hypoHDLemia. Specifically disclosed is a compound represented by the formula below or a pharmacologically acceptable salt thereof. [chemical formula 1] (In the formula, R1a-R1d respectively represent a hydrogen atom, a halogen atom, an optionally substituted alkyl group or an optionally substituted alkoxy group; and R2a and R2b respectively represent a hydrogen atom or an alkyl group which may have a substituent (such as a carboxyl group, an alkoxycarbonyl group, a carbamoyl group or an N-substituted carbamoyl group), or R2a and R2b may combine together and form a hydrocarbon ring together with an adjacent carbon atom. In this connection, R2a and R2b are not hydrogen atoms at the same time, or R2a and R2b are not methyl groups at the same time.)

Inventors:
YOKOYAMA SHINJI (JP)
KANAZAWA HASHIME (JP)
AOTSUKA TOMOJI (JP)
Application Number:
PCT/JP2007/072547
Publication Date:
May 29, 2008
Filing Date:
November 21, 2007
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV NAGOYA CITY (JP)
ASKA PHARM CO LTD (JP)
YOKOYAMA SHINJI (JP)
KANAZAWA HASHIME (JP)
AOTSUKA TOMOJI (JP)
International Classes:
C07D339/06; A61K31/381; A61P1/04; A61P1/16; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P5/16; A61P9/00; A61P9/10; A61P13/12; A61P19/08; A61P29/00; A61P35/00; A61P43/00
Domestic Patent References:
WO2005067904A12005-07-28
WO2005067904A12005-07-28
WO2000078971A22000-12-28
WO2000078972A22000-12-28
WO2001015676A22001-03-08
WO2005067904A12005-07-28
Foreign References:
US3862332A1975-01-21
JPS61218570A1986-09-29
Other References:
MARTIN B.N. ET AL.: "Synthesis and hypocholesterolemic activity of alkylidenedithio bisphenols", JOURNAL OF MEDICINAL CHEMISTRY, vol. 13, no. 4, 1970, pages 722 - 725, XP008104923
MIZUSHIMA Y.: "Konnichi no Chiryoyaku Kaisetsu to Binran '99", 1999, NANKODO CO., LTD., pages: 429 - 433, XP008117052
MAO S.J.T. ET AL.: "Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analog (MLD29,311) that does not lower serum cholesterol", ARTERIOSCLEROSIS AND THROMBOSIS, vol. 11, no. 5, 1991, pages 1266 - 1275, XP002507259
BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE, vol. 7-8, no. PT.2, 1973, pages 2297 - 2300
ANNUAL REVIEW OF CELL BIOLOGY, vol. 8, 1992, pages 67 - 113
LIPIDS, vol. 29, no. 12, 1994, pages 819 - 823
"Handbook of Pharmaceutical Excipients", 1989, MARUZEN CO., LTD.
"Japanese Pharmaceutical Excipients Dictionary 2000", March 2002, YAKUJI NIPPO LTD.
"Japanese Pharmaceutical Excipients Dictionary 2005", May 2005, YAKUJI NIPPO LTD.
"Pharmaceuticals,Revised2nd Edition", 1997, NANKODO,CO.,LTD.
"Japanese Pharmaceutical Excipients 2003", August 2003, YAKUJI NIPPO LTD.
See also references of EP 2070919A4
Attorney, Agent or Firm:
KUWATA, Mitsuo (6th Floor Minato Umeda Building,3-17, Nishitemma 6-chome,Kita-ku, Osaka-shi, Osaka 47, JP)
Download PDF: